GLP-3RT 10mg is a research-use-only peptide supplied in lyophilized powder form for qualified laboratory settings. GLP-3RT is intended for controlled laboratory investigation involving multi-receptor signaling pathways, including glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor systems.
Research Specifications
| Product Name |
GLP-3RT |
| Vial Quantity |
10mg |
| Form |
Lyophilized Powder |
| Research Classification |
Triple-Receptor Agonist Research Peptide |
| Research Targets |
GLP-1, GIP & Glucagon Receptor Pathways |
| Molecular Formula |
C₂₂₁H₃₄₂N₄₆O₆₈ |
| Molecular Weight |
4,731.4 g/mol |
| Research Identifier |
LY3437943 |
| CAS Number |
2381089-83-2 |
| Peptide Length |
39 residues |
| Intended Use |
Laboratory Research Only |
Triple-Receptor Agonist Research
GLP-3RT is associated with an emerging area of peptide research focused on the simultaneous investigation of GLP-1, GIP, and glucagon receptor pathways. This multi-receptor model allows researchers to investigate interactions among several metabolic and endocrine signaling systems rather than examining a single receptor pathway in isolation.
Scientific interest in this area has expanded through research involving compounds such as retatrutide, also identified in scientific literature by the development code LY3437943. Published research describes this class of molecule as exhibiting agonist activity across the GIP, GLP-1, and glucagon receptors.
GLP-1, GIP & Glucagon Signaling
GLP-1, GIP, and glucagon are peptide hormones associated with distinct but interconnected biological signaling pathways. Triple-receptor agonist models provide researchers with a framework for examining how simultaneous receptor activity differs from single- or dual-receptor experimental models.
Laboratory investigation of these pathways may include receptor activation, cellular signaling, metabolic pathway interactions, energy-homeostasis mechanisms, and comparative analysis of multi-receptor signaling.
The growing scientific literature surrounding retatrutide research and related triple-agonist models has made the interaction among these three receptor systems an increasingly prominent area of peptide research.
Molecular Research Profile
The research molecule associated with LY3437943 is a synthetic, lipid-modified peptide consisting of 39 residues. Its molecular architecture has been developed for simultaneous activity at the GIP, GLP-1, and glucagon receptors.
Reference chemical data identify a molecular formula of C₂₂₁H₃₄₂N₄₆O₆₈, a molecular weight of approximately 4,731.4 g/mol, and CAS Registry Number 2381089-83-2.
These molecular characteristics are provided as reference information for laboratory researchers and should be considered alongside applicable batch-specific analytical documentation.
Lyophilized Peptide
GLP-3RT is supplied as a freeze-dried, lyophilized powder. Lyophilization is used to support material stability and preserve compound integrity during appropriate laboratory storage.
Pinnacle Peptide Labs does not use fillers during the lyophilization process.
Batch-specific documentation may be included within the product gallery or made available for review where applicable.
Research Use Only
GLP-3RT 10mg is intended strictly for in vitro research, analytical testing, and laboratory investigation.
It is not intended for human consumption, animal consumption, clinical use, diagnostic use, therapeutic use, veterinary use, or for the treatment, cure, mitigation, or prevention of any disease.
